Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer
Condition:   Oropharyngeal Squamous Cell Carcinoma (SCC) Interventions:   Biological: PRGN-2009;   Drug: Pembrolizumab Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition:   Solid Tumor, Adult Intervention:   Drug: Vaccine Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials